[Federal Register: March 15, 2006 (Volume 71, Number 50)]
[Notices]
[Page 13410]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15mr06-134]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Science Board to the Food and Drug Administration; Notice of
Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Science Board to the Food and Drug
Administration Science Board (Science Board).
General Function of the Committee: The Science Board provides
advice primarily to the Commissioner of Food and Drugs and other
appropriate officials on specific complex and technical issues as well
as emerging issues within the scientific community in industry and
academia. Additionally, the Science Board provides advice to the agency
on keeping pace with technical and scientific evolutions in the fields
of regulatory science, on formulating an appropriate research agenda,
and on upgrading it's scientific and research facilities to keep pace
with these changes. It will also provide the means for critical review
of agency sponsored intramural and extramural scientific research
programs.
Date and Time: The meeting will be held on March 31, 2006, from 8
a.m. to 4 p.m.
Location: Food and Drug Administration, rm. 1066, 5630 Fishers
Lane, Rockville, MD 20857.
Contact Person: Jan Johannessen, Office of the Commissioner, Food
and Drug Administration (HF-33), 5600 Fishers Lane, Rockville, MD
20857, 301-827-6687, Jan.Johannessen@fda.hhs.gov, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 3014512603. Please call the Information Line
for up-to-date information on this meeting.
Agenda: The Science Board will conclude their discussion on drug
safety from the meeting of November 4, 2005, and will hear about and
discuss a request by the agency for a review of the agency's science
programs. The Science Board will then hear about and discuss the
agency's response to the recommendations contained in the Science
Board's peer review of the Office of Regulatory Affairs Pesticide
Program, plans for a Science Board peer review of the Center for
Veterinary Medicine's intramural portion of the National Antimicrobial
Resistance Monitoring System, and the science priorities of the
agency's Office of Women's Health.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by March 24,
2006. Oral presentations from the public will be scheduled between
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may
be limited. Those desiring to make formal oral presentations should
notify the contact person before March 24, 2006, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Jan Johannessen (see
Contact Person) at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: March 7, 2006.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. E6-3639 Filed 3-14-06; 8:45 am]
BILLING CODE 4160-01-S